Peripheral Artery Disease Market to Reach $10.8 billion, Globally, by 2035 at 7.7% CAGR: Allied Market Research

News provided by

May 16, 2024, 10:01 ET

PORTLAND, Ore., May 16, 2024 /PRNewswire/ -- Allied Market Research published a report, titled, "Peripheral Artery Disease Market by Product Type (Devices and Drugs), and End User (Hospitals and Specialty Clinics): Global Opportunity Analysis and Industry Forecast, 2024-2035". According to the report, the "peripheral artery disease market" was valued at $4.5 billion in 2023, and is estimated to reach $10.8 billion by 2035, growing at a CAGR of 7.7% from 2024 to 2035.

Request Sample of the Report on Peripheral Artery Disease Market Forecast 2035- https://www.alliedmarketresearch.com/request-sample/4315

Prime determinants of growth

The peripheral artery disease market is expected to grow significantly owing to rise in the prevalence of peripheral artery disease, surge in the geriatric population, and rise in the adoption of minimal invasive procedures. Furthermore, technological advancement in peripheral artery disease treatment devices is expected to present significant growth opportunities in the peripheral artery disease market.

Report coverage & details

Report Coverage	Details
Forecast Period	2024–2035
Base Year	2023
Market Size in 2023	$4.5 billion
Market Size in 2035	$10.8 billion
CAGR	0.077
No. of Pages in Report	280
Segments covered	Product Type, End User, and Region
Regional scope	North America, Europe, Asia-Pacific, and LAMEA
Country scope	U.S., Canada, Mexico, Germany, France, the UK, Italy, Spain, Rest of Europe, Japan, China, India, Australia, South Korea, Rest of Asia-Pacific, Brazil, Saudi Arabia, South Africa, and Rest of LAMEA
Drivers	Rise in prevalence of peripheral artery disease
	Surge in the geriatric population
	Rise in the adoption of the minimal invasive procedures
Opportunity	Technological advancement in peripheral artery disease treatment devices
Restraint	High cost of peripheral artery disease treatment devices

Want to Explore More, Connect to our Analyst- https://www.alliedmarketresearch.com/connect-to-analyst/4315

The drug segment to maintain its leadership status throughout the forecast period

By product type, the drug segment held the highest market share in 2023 and is expected to dominate during the forecast period, accounting for three-fifths of the peripheral artery disease market revenue, owing to the regular need of drugs to control blood cholesterol levels to avoid progression of peripheral artery disease.

The hospitals segment to maintain its leadership status throughout the forecast period

By end user, the hospitals segment held the highest market share in 2023, accounting for more than half of peripheral artery disease market revenue owing to peripheral artery disease often requiring complex diagnostic procedures, medical management, and interventional treatments such as angioplasty, stenting, or bypass surgery. Hospitals are equipped with the necessary infrastructure, including specialized imaging facilities, operating rooms, and skilled medical professionals, to deliver these treatments effectively.

However, the specialty clinics segment is expected to register the highest CAGR during the forecast period, owing to specialty clinics being typically more efficient and cost-effective than hospitals for certain peripheral artery disease related services. With lower overhead costs and streamlined processes, specialty clinics can provide high-quality care at competitive prices, appealing to patients and payers alike.

For Purchase Enquiry- https://www.alliedmarketresearch.com/purchase-enquiry/4315

North America to maintain its leadership status throughout the forecast period

By region, North America held the highest market share in 2023, accounting for more than one-third of peripheral artery disease market revenue. This is attributed to the strong presence of key players in the region, well-developed healthcare infrastructure, and rise in the prevalence of peripheral artery disease. However, Asia-Pacific is expected to register a noteworthy CAGR during the forecast period, owing to rise in the geriatric population and surge in the prevalence of cardiovascular disease.

Leading Market Players

Philips N.V.
Braun Melsungen AG
Medtronic
Bayer AG
Boston Scientific Corporation
Becton Dickinson and Company
Terumo Medical Corporation
Biotronik
Cardinal Health
Abbott

The report provides a detailed analysis of these key players in the peripheral artery disease market. These players have adopted different strategies such as product approval, to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario

AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:

AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.

Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int'l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
[email protected]
Web: https://www.alliedmarketresearch.com
Follow Us on: LinkedIn